News
DMTRF
2.860
NaN%
--
3-D Matrix and Harvard Achieve Breakthrough in Cardiac Regenerative Therapy
TipRanks · 10/17/2025 07:22
Weekly Report: what happened at DMTRF last week (0908-0912)?
Weekly Report · 09/15/2025 09:41
Weekly Report: what happened at DMTRF last week (0825-0829)?
Weekly Report · 09/01/2025 09:41
Weekly Report: what happened at DMTRF last week (0818-0822)?
Weekly Report · 08/25/2025 09:44
Weekly Report: what happened at DMTRF last week (0811-0815)?
Weekly Report · 08/18/2025 09:42
Weekly Report: what happened at DMTRF last week (0804-0808)?
Weekly Report · 08/11/2025 09:44
Weekly Report: what happened at DMTRF last week (0728-0801)?
Weekly Report · 08/04/2025 09:45
Weekly Report: what happened at DMTRF last week (0721-0725)?
Weekly Report · 07/28/2025 09:46
Weekly Report: what happened at DMTRF last week (0714-0718)?
Weekly Report · 07/21/2025 09:42
Weekly Report: what happened at DMTRF last week (0707-0711)?
Weekly Report · 07/14/2025 09:45
Weekly Report: what happened at DMTRF last week (0630-0704)?
Weekly Report · 07/07/2025 09:43
Weekly Report: what happened at DMTRF last week (0623-0627)?
Weekly Report · 06/30/2025 09:45
More
Webull provides a variety of real-time DMTRF stock news. You can receive the latest news about 3 D Matrix through multiple platforms. This information may help you make smarter investment decisions.
About DMTRF
3-D Matrix Ltd is a Japan-based company mainly engaged in medical products business. Its Medical Products Business consists of the development and sales of medical products. Based on self-assembling peptide technology, it conducts research and development of medical devices and pharmaceuticals in the surgical, tissue regeneration, and drug delivery system (DDS) fields. Major development pipelines include absorbable topical hemostatic agents, mucosal elevation agents, post-bleeding prevention agents, next-generation hemostatic agents, and adhesion prevention agents in the surgical field, wound healing agents and alveolar bone reconstruction agents in the tissue regeneration field, and DDS for nucleic acid drugs in the DDS field.